Pyxis Oncology, Inc. (PYXS)

4.41 +0.12 (+2.80%) USD  |  NASDAQ  |  Dec 11, 16:00
4.41 0.00 (0.00%) Pre-Market: 09:18
More

Pyxis Oncology Gross Profit (Quarterly): -0.527M for Sept. 30, 2025

Gross Profit (Quarterly) Chart

View Gross Profit (Quarterly) for PYXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

View Gross Profit (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Quarterly) Benchmarks

View Gross Profit (Quarterly) Benchmarks
Start Trial
Plus Therapeutics, Inc. 1.311M
Pfizer Inc. 11.18B
Ironwood Pharmaceuticals, Inc. 121.58M
Akebia Therapeutics, Inc. 49.06M
PTC Therapeutics, Inc. 187.69M